New Insights on Non‐enzymatic Glycosylation May Lead to Therapeutic Approaches for the Prevention of Diabetic Complications

Diabetic Medicine

Volumn 9, Issue 3, 1992, Pages 297-299

  Ceriello, A ^a   Quatraro, A ^b   Giugliano, D ^c  

^a UNIVERSITY OF UDINE   (Italy)

^b Policlinico MultiMedica   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Antioxidants; Glycosylation; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; FREE RADICAL; SCAVENGER;

DIABETES MELLITUS; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA; PRIORITY JOURNAL; SHORT SURVEY;

ANTIOXIDANTS; DIABETES MELLITUS; GLYCOPROTEINS; GLYCOSYLATION; HUMAN; HYPERGLYCEMIA;

EID: 0026562860     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.1992.tb01783.x     Document Type: Article

References (33)

1. The biochemistry of the complications of diabetes mellitus
2. Role of advanced glycosylation products in complications of diabetes
3. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
4. Relation between complications of type I diabetes mellitus and collagen‐linked fluorescence
5. Collagen‐linked fluorescence is increased in the skin of young patients with type I (insulin‐dependent) diabetes mellitus
6. Chemistry of nonenzymatic browning. I
7. Chemistry of nonenzymatic browning. II
8. Nonenzymatic browning products: physiologic effects and metabolic transit in relation to chemical structure: a review
9. Nonenzymatic browning via the Maillard reaction in foods
10. Glucose auto‐oxidation and protein modification. The potential role of ‘autoxidative glyco‐sylation’ in diabetes
11. Hydroxyl radical production and autoxidative glycosylation. Glucose autoxidation as the cause of protein damage in the experimental glycation model of diabetes mellitus and ageing
12. Effects of ascorbic acid on nonenzymatic glycation of serum proteins in vitro and in vivo
13. Ascorbic acid inhibits non enzymatic glycation of collagen type I, IV, IX, XI, in vitro and renal basement membrane in vivo
14. A preliminary note on inhibiting effect of alpha‐tocopherol (vitamin E) on protein glycation
15. Vitamin E reduction of protein glycosylation in diabetes. New prospect for the prevention of diabetic complications?
16. Inhibitory effect of superoxide dismutase on fructosamine assay
17. Glycation of proteins as a source of superoxide
18. Superoxide production from nonenzymatically glycated proteins
19. Superoxide radical generation by Amadori compound
20. Captopril inhibits fluorescence development in non‐enzymatically glycosylated proteins
21. New approaches to the pathogenesis and treatment of diabetic microangiopathy
22. Role of oxidative stress in development of complications in diabetes
23. Pathogenesis of diabetic microangiopathy: an overview
24. Free radicals and diabetes
25. Lipid peroxide level in serum of diabetic patients
26. Metabolic control may influence the increased superoxide anion generation in diabetic serum
27. Evidence for a possible role of oxygen free radicals in the abnormal functional arterial vasomotion in insulin‐dependent diabetes
28. Antioxidants show an anti‐hypertensive effect in diabetic and hypertensive subjects
29. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells
30. Oxidation of spectrin and deformability defects in diabetic erythrocytes
31. Does a common mechanism induce the diverse complications of diabetes?
32. Protection by free radical scavenging enzymes against glucose‐induced embryonic malformations in vitro
33. Antioxidants normalize delayed human endothelial cells replication in hyperglycemic media